Please Wait
Applying Filters...
menu
    • menu
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Pegilodecakin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Krystal Bio Receives FDA RMAT Designation For KB707 In Advanced
    Krystal Bio Receives FDA RMAT Designation For KB707 In Advanced

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234467/0/en/Krystal-Biotech-Announces-RMAT-Designation-Granted-by-FDA-to-KB707-for-the-Treatment-of-Advanced-or-Metastatic-Non-Small-Cell-Lung-Cancer.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share
    VAS101, Novel Curcumin Formulation Reverses Aging Hallmarks
    VAS101, Novel Curcumin Formulation Reverses Aging Hallmarks

    17 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/vas101-a-novel-curcumin-transdermal-formulation-reverses-some-clinical-hallmarks-of-aging-302403204.html

    PR NEWSWIRE
    17 Mar 2025
    Share Share
    UCB To Share BIMZELX Two-Year Data In Arthritis At EULAR 2024
    UCB To Share BIMZELX Two-Year Data In Arthritis At EULAR 2024

    12 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ucb-to-share-first-presentations-of-bimzelx-bimekizumab-bkzx-two-year-data-in-axial-spondyloarthritis-and-psoriatic-arthritis-at-eular-2024-302170292.html

    PR NEWSWIRE
    12 Jun 2024
    Share Share
    Cue Biopharma Doses First Patient in Phase 1 Study of CUE-102
    Cue Biopharma Doses First Patient in Phase 1 Study of CUE-102

    22 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/22/2502147/0/en/Cue-Biopharma-Doses-First-Patient-in-Phase-1-Study-of-CUE-102-for-Wilms-Tumor-1-WT1-expressing-cancers.html

    GLOBENEWSWIRE
    22 Aug 2022
    Share Share
    NeoImmuneTech Begins Dosing in Phase 1b Study of NT-I7 and Kymriah in r/rLBCL
    NeoImmuneTech Begins Dosing in Phase 1b Study of NT-I7 and Kymriah in r/rLBCL

    13 Oct 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211013005218/en

    BUSINESSWIRE
    13 Oct 2021
    Share Share
    Calypso Biotech Announces First Patient dosed with CALY-002
    Calypso Biotech Announces First Patient dosed with CALY-002

    09 Sep 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210908006073/en/Calypso-Biotech-Announces-First-Patient-With-Celiac-Disease-Dosed-in-anti-Interleukin-15-IL-15-Monoclonal-Antibody-CALY-002-Phase-1b-Trial-and-Extension-of-Series-A-to-%E2%82%AC28M

    BUSINESSWIRE
    09 Sep 2021
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.